Zituvimet Tablet, Film Coated
Product Images NDC 70771-1860
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvimet (NDC 70771-1860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structure (F9c7f395 5f9f 4682 B3f4 Ed27e5ec62d8 02)
Graph (F9c7f395 5f9f 4682 B3f4 Ed27e5ec62d8 03)
Graph (F9c7f395 5f9f 4682 B3f4 Ed27e5ec62d8 04)
Label (F9c7f395 5f9f 4682 B3f4 Ed27e5ec62d8 05)
This text provides information about a medication called "Sitagliptin and Metformin HCI" in tablet form. Each film-coated tablet contains Sitagliptin 50mg and Metformin Hydrochloride USP 500mg. The recommended dosage is specified in the prescribing information. The packaging is child-resistant and should be kept out of reach of children. It is advised to store the medication at controlled room temperature, between 15°C and 30°C, to protect it from moisture. Once the bottle is opened, the product must be used within 3 months. After 3 months, the medication should be discarded. Additional details and a medication guide are available on the website www.zydususa.com. The package contains 60 tablets and further assistance can be obtained by calling 1-877-983-4775.*
Label (F9c7f395 5f9f 4682 B3f4 Ed27e5ec62d8 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.